Rhode Island – Attorney General Peter F. Kilmartin today announced an amended agreement with Naloxone manufacturer Amphastar Pharmaceuticals, Inc., that would increase the company-offered rebate for each Naloxone kit (syringe dosage only) purchased by non-federal government agencies in Rhode Island from $4 per dose to $6 per dose. The rebate is retroactive for purchases made […]readmore
